Archive | December, 2009
Taro Announces T2007 Clinical Trials (OTC:TAROF)
Taro Pharmaceutical Industries Ltd (OTC:TAROF) has announced that they have begun the Phase 1 of clinical trials in Canada with T2007 which is second in the Company’s class of proprietary non-sedating barbiturate compounds to be approved for studies in humans.
Continue reading...Somaxon Scheduled To Meet FDA (NASDAQ:SOMX)
23 December 2009 – 1:35 pm PST
Comments Off
Somaxon Pharmaceuticals, Inc (NASDAQ:SOMX) has announced that they have scheduled to meet with the US Food and Drug Administration (FDA) on January 20, 2010 to discuss the New Drug Application (NDA) for Silenor which will be used for the treatment of insomnia.
Continue reading...Enzon Sets Special Meeting of Stockholders (NASDAQ:ENZN)
23 December 2009 – 1:32 pm PST
Comments Off
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) has announced that they have set Wednesday, January 27, 2010 as the date of the special meeting of stockholders to vote on the proposed sale of its specialty pharmaceutical business to the sigma-tau Group.
Continue reading...ARCA Submits New SPA (NASDAQ:ABIO)
23 December 2009 – 1:29 pm PST
Comments Off
ARCA Biopharma, Inc (NASDAQ:ABIO) has announced that they have submitted a study protocol for review under Food and Drug Administration’s Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the safety and efficacy of Gencaro.
Continue reading...Xcorporeal Signs Purchase Agreement (OTC:XCRP)
23 December 2009 – 1:29 pm PST
Xcorporeal Inc (OTC:XCRP) has announced that they have signed an asset purchase agreement with National Quality Care Inc (NQCI) and Fresenius USA, Inc to sell substantially all of the assets of the Seller to the Purchaser for an aggregate cash price of $8,000,000.
Continue reading...Arrowhead Raises New Funds (NASDAQ:ARWR)
23 December 2009 – 1:26 pm PST
Comments Off
Arrowhead Research Corporation (NASDAQ:ARWR) has announced that they have raised approximately $3.2 million in gross proceeds from a private placement of approximately 6.0 million units.
Continue reading...Bullish Breakout Technical Alert (OTC:BZCN)
23 December 2009 – 1:25 pm PST
Comments Off
TheMarketFinancial has initiated an independent bullish technical trading alert on BizAuctions Inc. (OTC:BZCN.OB). Shares of the company finished the day at $0.0018, up 5.88% from the opening bell on heavy buying pressure. The stock reached an intraday high of $0.0022 which seemed to be a major resistance, thus causing it to fall near the $0.0016 [...]
Continue reading...ProtoKinetix Receives European Proposals (OTC:PKTX)
16 December 2009 – 10:05 am PST
Comments Off
ProtoKinetix Inc (OTC:PKTX) has announced that they have recently been approached by a European biopharma investment group with a series of proposals for development of commercial partnerships in the areas like pharmaceuticals and cosmetics.
Continue reading...Advaxis Collaborates with NCI (OTC:ADXS)
16 December 2009 – 9:55 am PST
Advaxis Inc (OTC:ADXS) has announced that they will be collaborating their Phase 2 trial with the Gynecologic Oncology Group which is a collaborative research of National Cancer Institute.
Continue reading...Emisphere Reports DMC Recommendation (OTC:EMIS)
15 December 2009 – 7:45 am PST
Comments Off
Emisphere Technologies Inc (OTC:EMIS) has announced that an independent Data Monitoring Committee (DMC) has informed Novartis and its partner Nordic Bioscience about their recommendation to proceed with the Osteoporosis (OP) Phase 3 study and the Osteoarthritis (OA) Phase 3 Study exploring the safety and efficacy of an oral formulation of salmon calcitonin to treat patients [...]
Continue reading...
23 December 2009 – 1:37 pm PST
Comments Off